DoW Parkinson’s, Early Investigator Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 18, 2026
- Amount
- Program total $4.2M
- Closes
- Nov 6, 2026 (in 51 days)
Similar opportunities open now
- DoW Parkinson’s, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 51 days
- DoW Bone Marrow Failure, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
- DoW Kidney Cancer, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 12 days
- DoW Duchenne Muscular Dystrophy, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 2 days
- DoW Duchenne Muscular Dystrophy, Clinical/Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 2 days
Classification and identifiers
- Solicitation number
- HT942526PRPEIRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $4.2M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) research for investigators in the early stages of their careers. The FY26 EIRA offers two funding levels, which align to the research career stage of the Principal Investigator (PI). Funding Level 1 (for fellows) requires the investigator to receive guidance from a designated Mentor, whereas Funding Level 2 (for early-career independent investigators) does not. Proposed research must address at least one of the four FY26 PRP Focus Areas . Distinctive Features: · The Early Investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as an investigator at the forefront of PD researc...